Can assist in cartilage repair
The compound is not FDA-approved, and further clinical studies are needed to fully understand its safety profile for continued use
Retatrutide is in active Phase 3 clinical development under Eli Lilly's TRIUMPH programme
Dulaglutide can restore the expression of these genes by inhibiting their methylation levels, thereby facilitating the reversion of tumor cells to their epithelial phenotype and suppressing tumor progression and invasive capabilities
As a skin brightening ingredient, glutathione for melasma reduces oxidative stress and reduces melanin production that supports gradual brightening and prevents worsening the hyperpigmentation
Broad cytoprotective signaling, including ERK1/2 and FAKpaxillin activation, which enhance cell survival, adhesion, and motility at injury sites